Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4294
Publisher
MDPI AG
Online
2021-04-22
DOI
10.3390/ijms22094294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
- (2021) Alessia Furgiuele et al. Journal of Neuroimmune Pharmacology
- Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization
- (2021) Omer Anis et al. MOLECULES
- Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
- (2021) Clara Andradas et al. Cancers
- Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
- (2020) Cifelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
- (2020) Meir Bialer et al. EPILEPSIA
- Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
- (2020) Viviana di Giacomo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation
- (2020) James M. Nichols et al. Journal of Neuroimmune Pharmacology
- The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
- (2020) Willian Lazarini-Lopes et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Promising in vitro antioxidant, anti‐acetylcholinesterase and neuroactive effects of essential oil from two non‐psychotropic Cannabis sativa L. biotypes
- (2020) Antonella Smeriglio et al. PHYTOTHERAPY RESEARCH
- Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602
- (2020) Tiyyaba Furqan et al. Biomolecules
- The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
- (2020) Oliviero Marinelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids
- (2020) Sarah H. Shrader et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq
- (2020) Fengjin Hao et al. LIFE SCIENCES
- Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
- (2020) R. Cooray et al. MOLECULAR NEUROBIOLOGY
- A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
- (2020) Éamon Jones et al. MOLECULES
- Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature
- (2020) Stefano Pagano et al. BIOMEDICINE & PHARMACOTHERAPY
- Phenolic Compounds Cannabidiol, Curcumin and Quercetin Cause Mitochondrial Dysfunction and Suppress Acute Lymphoblastic Leukemia Cells
- (2020) Miguel Olivas-Aguirre et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma
- (2020) Yoon Young Go et al. Scientific Reports
- Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells
- (2019) Soyeon Jeong et al. CANCER LETTERS
- Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells
- (2019) Esraah Alharris et al. Oncotarget
- Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
- (2019) Paula B. Dall'Stella et al. Frontiers in Oncology
- Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells
- (2019) Vladimir N. Ivanov et al. Oncotarget
- miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia—Effect of cannabinoids
- (2019) Ana Juknat et al. PLoS One
- Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
- (2019) Serena Silvestro et al. MOLECULES
- Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia
- (2019) Carlos Jimenez Naranjo et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
- (2019) Miguel Olivas-Aguirre et al. Cell Death & Disease
- Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer
- (2019) Soyeon Jeong et al. Cell Death & Disease
- The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
- (2019) Keith A. Kwan Cheung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
- (2018) Blathnaid Hughes et al. NEUROCHEMICAL RESEARCH
- Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats
- (2018) Eric Murillo-Rodríguez et al. NEUROCHEMICAL RESEARCH
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next
- (2018) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload
- (2018) Vanessa Kappel da Silva et al. Translational Psychiatry
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
- (2017) Brian D. Klein et al. NEUROCHEMICAL RESEARCH
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Acetylcholinesterase, butyrylcholinesterase and paraoxonase 1 activities in rats treated with cannabis, tramadol or both
- (2016) Omar M.E. Abdel-Salam et al. Asian Pacific Journal of Tropical Medicine
- Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis
- (2016) Emma Banwell et al. Multiple Sclerosis and Related Disorders
- Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner
- (2015) Massimo Nabissi et al. INTERNATIONAL JOURNAL OF CANCER
- Cannabinoids and Epilepsy
- (2015) Evan C. Rosenberg et al. Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- ILAE Official Report: A practical clinical definition of epilepsy
- (2014) Robert S. Fisher et al. EPILEPSIA
- Phytocannabinoids and epilepsy
- (2014) R. G. dos Santos et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) V. Yadav et al. NEUROLOGY
- Therapeutic Potential of Cannabinoids—Perspectives for the Future
- (2014) Joanna Makowiecka et al. Journal of Natural Fibers
- Therapeutic Potential of Cannabinoids—Retrospective and Historical Developments
- (2014) Joanna Makowiecka et al. Journal of Natural Fibers
- Drug treatment of epilepsy in adults
- (2014) D. Schmidt et al. BMJ-British Medical Journal
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
- (2013) Emelie Janefjord et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
- (2013) Marta Solinas et al. PLoS One
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol inhibits angiogenesis by multiple mechanisms
- (2012) M Solinas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
- (2012) Massimo Nabissi et al. CARCINOGENESIS
- Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
- (2012) Verena Isabell Leussink et al. Therapeutic Advances in Neurological Disorders
- Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
- (2011) A. Shrivastava et al. MOLECULAR CANCER THERAPEUTICS
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging
- (2011) Alexei A. Podtelezhnikov et al. PLoS One
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease
- (2009) Qingguang Jiang et al. CNS DRUGS
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoids, multiple sclerosis and neuroprotection
- (2009) Eva de Lago et al. Expert Review of Clinical Pharmacology
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid pharmacology: the first 66 years
- (2006) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now